Pharmaceutical Regulatory Affairs in Asia including India
19-21 January, London:  This outstanding seminar focuses on R&D-based pharmaceutical products in Asia. Topics include: The Markets, Outlines of Company and Product Registration, Application Process, Recent Regulatory Developments in the Region, Harmonisation Initiatives including ASEAN Opportunities, General Country Specific and Regional Discussions. Gain practical knowledge and valuable insights into this huge market.

                 
                  
CBI’s Premier Bio/Pharmaceutical Legal and Regulatory Product Lifecycle Strategies
20-21 January, Baltimore:  Bio/pharma companies are facing soaring R&D costs, shrinking pipelines and increased generic competition, as well as competition from other brand names in the same therapeutic class. To compete in this changing environment, lifecycle management has been gaining popularity as a way to maximize product value throughout the lifespan. However, traditional LCM strategies are not going to suffice in current times. This conference addresses the current challenges, policies and practical strategies from both legal and regulatory perspectives to help companies implement a more effective and modern approach to LCM.

               

4th Annual Marketing & Sales in Generics
20-21 January, Prague:  What marketing & sales strategies are successful generics companies using? Are you able to achieve differentiation in the market? Strengthen your competitive position by capturing the opportunities in mature and emerging generics markets. Profit from the patent expiries. Improve your segmentation techniques. To succeed in global markets, generic players must excel in understanding the changing regulatory & pricing environment. We bring you experts from the generics industry to benchmark their direct experiences with marketing, sales & distribution models.

Asia Pharma Expo - 2009
22-24 January, Bangladesh:  A Land mark for the entire South Asian Pharmaceutical industry.  The pharma event of international standards is being organised in Bangladesh. Expected international participation of more than 400 exhibitors from India, Bangladesh, China, European Union, USA, Korea, Indonesia, Thailand, Malaysia, Singapore and Burma etc. Bangladesh has all the potential to become a major global source of Active Pharmaceutical Ingredients (API) as based on the Doha declaration, the country will also be able to produce drugs which are still under patent protection until 2015.

Biotech and Pharmaceutical Patenting
26-27 January, London:  This in-depth and specialised conference will focus on the more difficult aspects of patents, offering a variety of views from patent practitioners, an EPO representative and a member of the European Commission. Of particular interest to Patent Attorneys, Patent Counsel, as well as IP Lawyers from a wide geographical and industrial background, this conference will explain how to deal with the unusual loops and nuances that can arise.

InformexUSA
27-30 January, San Francisco: As the premier event for the chemical industry in the United States, InformexUSA is designed to showcase the chemistry capabilities of high-value, high-quality businesses in the chemical manufacturing industry. Companies that invest in R&D, quality systems, applications development, and more.

8th Annual Project and Portfolio Management for Pharma
29-30 January, Barcelona:  Hear from major players in pharma discussing the key PPM issues impacting industry right now. Learn how to achieve a harmonious balance between marketing, PPM and R&D functions and optimise PPM strategies and operations. Discuss winning measures to maximise long-term growth and profitability in an open, interactive forum and benefit from extensive networking opportunities with your peers.

8th EGA Regulatory and Scientific Affairs Conference
29-30 January, Amsterdam:  Issues to be covered include: New legislative initiatives from the European Commission, an efficient regulatory system in Europe – how to use existing resources in the most efficient way, what improvements does the revised Variations Regulation bring to the authorities and the industry, initial conclusions from the sectorial enquiry on anticompetitive regulatory practices, implementation of the eCTD – survey among authorities and industry on the readiness of eCTD applications, how to keep the PIL and SmPC of generic medicines up-to-date in view of changes to the reference product.

2nd Annual CEE Clinical Trials
4-6 February, Vienna:  As pharmaceutical and biotechnology companies working in CEE countries are facing many new challenges,our conference brings you an excellent opportunity to network with industry peers and learn from leaders in the industry.Join us to share your experiences and challenges and learn about successful strategies and solutions.You can expect the latest regulatory updates, exciting case studies including updates from emerging markets, effective strategies for contracting and techniques for motivating investigators.  We will also discuss new features and technologies in clinical trials, ethical concerns and the potential of interactive educational training of CT staff.

Pharma/Biotech Patent Litigation
17-18 February, Amsterdam:  The latest information on European and US case law developments, the EU Sector Inquiry and the most successful strategies to manage multijurisdictional litigation. Don’t miss this opportunity to meet with fellow practitioners with extensive experience of litigating patent claims. Share litigation strategies with your peers and improve your ability to determine the likelihood of enforcement and ultimately the success of litigation.

Pharmtech Congress
17-18 February, Poland:  Attendees at the PHARMtech Congress are given the opportunity to meet senior representatives from leading vendor companies at home in Central and Eastern Europe. New-to-market products, services and technologies, relevant to all in pharmaceutical manufacturing industry, provide a complete market overview of cutting edge manufacturing solutions.

GPhA Annual Meeting 2009
23-25 February, Florida:  Join us for GPhA's Annual Meeting and 25th industry anniversary celebration on February 23 – 25. Top speakers and unparalleled networking make this the generic pharmaceutical event of the year. More than 500 attendees convene in Naples, Florida for perspective on the most important emerging issues facing the generic pharmaceutical sector.

EU Commission - proposals for new Pharmaceutical Legislation
25-26 February, Brussels:  This joint TOPRA / European Commission meeting provides a unique opportunity, early in the legislation process, to gain an understanding of what is proposed in 'Information for Patients' section of the Pharma Package, and to hear from the Commission, from those it will affect and from critical observers. It will help you to form your own views on what is to be welcomed and what might be improved.  This will be an essential meeting for everyone who has an interest in companies' 'Information for Patients' activities and their regulation.

Advanced European Regulatory Affairs
25-27 February, London:  Exploring and assessing current European legislation and identify common problems - Overcoming the challenges presented by continued changes to European regulatory affairs - Examining the pros and cons of the globalisation of regulatory affairs - Determining the role of the Regulatory Affairs Manager - Successful strategies to ensure compliance with current regulatory affairs - Avoiding the pitfalls of new European regulations - Developing and maintaining labelling strategies to conform with the regulatory affairs of your target market location - Managing pharmacovigilance in an ever changing world - Optimising the effectiveness of your pharmacovigilance system - Expeditious product lifecycle management.

World Generic Medicines Congress Europe 2009
24-27 February, London:  World Generic Medicines Congress is Europe’s largest strategic generics meeting of choice for industry leaders. The 3rd annual event is bigger and better than ever before.Hear from and meet; Teva, Sandoz, Mylan, Hospira, Actavis, Alliance Boots, Novartis, Celesio, Insmed, Zentiva, Dr Reddy and Beijing Double Crane, amongst others.Networking activities are unrivalled and include; Speed Networking, the online Contact System, U Turn, and the Gala Dinner. clients.

EuroPLX39
2-3 March, Lisbon:  A pharma industry partnering event with industry delegates from all over the world.Historically, this partnering event delivers an average of more than 23 pre-scheduled appointments per participating company for Collaborative Agreements in Generics (incl. Bio-generics and Biosimilars), OTC Drugs, and Nutraceuticals - Development, Licensing, Marketing and Distribution. In addition, attending companies are expected to offer or look for R&D services, supporting technologies (e.g. new drug delivery, medical devices), contract manufacture, and, to some extent, the supply of APIs and intermediates.

             


8th Annual Global Generics Strategy Summit
4-5 March, Barcelona:  As the most established summit of its kind in the Generic pharmaceutical sector, Informa Life Sciences realises more than ever the changing landscape and needs of the industry. To reflect this, the 2009 agenda will see a brand new look. The 2009 agenda has been carefully crafted through the joint efforts of the advisory board.

             

2nd Annual Summit on Biosimilars and Follow-on Biologics
10-11 March, Baltimore:  Key topics to be addressed at this two-day conference will include World Health Organization (WHO) guidance for globally accepted biosimilar standards, exclusivity issues in proposed legislation, the European Union approval pathway, and testing, distribution and pricing of biosimilars in Brazil, China and India.

DCAT week
16-19 March, New York:  Through meetings, educational seminars and other events, DCAT members are afforded a variety of benefits and business development opportunities. Programs and events give member representatives the chance to learn new industry information and trends as well as make important contacts, dialogue with counterparts in other member companies and build relationships with current and potential customers.

Interphex 2009
17-19 March, New York:  INTERPHEX is the only Life Sciences event that represents a true cross-section of the pharmaceutical and biopharmaceutical industries. Industry-leading professionals worldwide make INTERPHEX the industry's annual focal point for driving change and efficiencies for the global pharmaceutical and biopharmaceutical market. INTERPHEX will once again partner with BIOTECHNICA, the leading biotechnology show in Europe, to feature BIOTECHNICA AMERICA making INTERPHEX the most comprehensive annual gathering in the life sciences industry!